AngioDynamics, Inc. (ANGO) — Financial statements
Income statement, balance sheet, and cash flow for AngioDynamics, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 292↓3.8% | 304↓10.3% | 339↑7.1% | 316↑8.7% | 291 | |
| Cost of Revenue | 135↓9.7% | 149↓9.3% | 165↑9.3% | 150↑12.1% | 134 | |
| Gross Profit | 158↑1.9% | 155↓11.2% | 174↑5.1% | 166↑5.7% | 157 | |
| Operating Expenses | ||||||
| R&D Expenses | 26↓16.8% | 32↑5.5% | 30↓2.8% | 31↓15.5% | 36 | |
| General & Administrative Expenses | 42↑2.3% | 41↑2.9% | 40↑4.0% | 38↑7.1% | 36 | |
| Selling & Marketing Expenses | 103↑0.3% | 103↓1.4% | 104↑9.4% | 95↑17.2% | 81 | |
| SG&A Expenses | 145↑0.9% | 144↓0.2% | 144↑7.9% | 134↑14.1% | 117 | |
| Other Expenses | 26↓84.7% | 172↑234.6% | 51↑72.6% | 30↓22.7% | 38 | |
| Operating Expenses | 198↓43.1% | 347↑54.0% | 225↑16.1% | 194↑1.1% | 192 | |
| Total Costs & Expenses | 332↓33.0% | 496↑27.3% | 390↑13.1% | 345↑5.6% | 326 | |
| Operating Results | ||||||
| Operating Income | -40↑79.2% | -192↓276.0% | -51↓79.8% | -28↑19.3% | -35 | |
| Depreciation & Amortization | 26↓6.9% | 28↓10.2% | 31↑5.2% | 29↑13.2% | 26 | |
| EBITDA | 2↑128.3% | -6↓150.3% | 12↑9.5% | 11↑220.0% | -9 | |
| EBIT | -24↑28.9% | -34↓81.2% | -19↓2.5% | -18↑48.2% | -35 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.98↓39.4% | 2↑159.7% | -3↓292.7% | -0.69↑20.1% | -0.86 | |
| Interest Income | 0.98↓39.4% | 2 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00↓100.0% | 3↑292.7% | 0.69↓20.1% | 0.86 | |
| Non-Operating Income | -16↑90.0% | -159↓387.9% | -33↓217.0% | -10↓11045.7% | -0.09 | |
| Other Income / Expenses | 6↑643.0% | 0.80↑124.5% | -3↓120.3% | -1↓92.2% | -0.77 | |
| Income Before Tax | -34↑82.2% | -192↓252.0% | -54↓81.8% | -30↑16.9% | -36 | |
| Income Tax Expense | -0.04↑99.5% | -7↓265.4% | -2↑41.4% | -3↑24.5% | -5 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -34↑81.6% | -184↓251.5% | -52↓97.5% | -27↑15.9% | -32 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -34↑81.6% | -184↓251.5% | -52↓97.5% | -27↑15.9% | -32 | |
| Bottom-Line Net Income | -34↑81.6% | -184↓251.5% | -52↓97.5% | -27↑15.9% | -32 | |
| EPS (Basic) | -0.83↑81.9% | -4.59↓245.1% | -1.33↓95.6% | -0.68↑17.1% | -0.82 | |
| EPS (Diluted) | -0.83↑81.9% | -4.59↓245.1% | -1.33↓95.6% | -0.68↑17.1% | -0.82 | |
| Weighted Average Shares | 41↑2.0% | 40↑1.8% | 39↑1.2% | 39↑1.7% | 38 | |
| Weighted Average Diluted Shares | 41↑2.0% | 40↑1.8% | 39↑1.2% | 39↑1.7% | 38 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.